Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Biomedicines|September 23, 2022
The Influence of SARS-CoV-2 Infection on Lipid Metabolism-The Potential Use of Lipid-Lowering Agents in COVID-19 ManagementKlaudia Kowalska, Zofia Sabatowska, Joanna Forycka, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Empagliflozin-A New Chance for Patients with Chronic Heart FailureKlaudia Kowalska, Justyna Walczak, Joanna Femlak, et al.Metabolites|August 26, 2021
Metabolomic Profile in Venous Thromboembolism (VTE)Beata Franczyk, Anna Gluba-Brzózka, Janusz Ławiński, et al.International Journal of Molecular Sciences|August 5, 2017
Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its OutcomeJacek Rysz, Anna Gluba-Brzózka, Beata Franczyk, et al.International Journal of Molecular Sciences|March 11, 2023
The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative ReviewBeata Franczyk, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, et al.International Journal of Molecular Sciences|September 14, 2024
The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease RiskAnna Gluba-Sagr, Beata Franczyk, Aleksandra Rysz-Górzyńska, et al.International Journal of Molecular Sciences|May 11, 2024
SGLT2 Inhibitors in Kidney Diseases-A Narrative ReviewAgata Gajewska, Jakub Wasiak, Natalia Sapeda, et al.Biomedicines|January 21, 2023
Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell CarcinomaBeata Franczyk, Jacek Rysz, Janusz Ławiński, et al.Current Vascular Pharmacology|January 16, 2016
The Problem of Atrial Fibrillation in Patients with Chronic Kidney DiseaseBeata Franczyk, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, et al.Biomedicines|August 26, 2022
Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery DiseaseWeronika Frąk, Armanda Wojtasińska, Wiktoria Lisińska, et al.Pageof 14